Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation; Chronic Kidney Diseases; Diabetes Mellitus, Type 2 Interventions: Other: Intervention group Sponsors: Prof. Dr. Folkert W. Asselbergs; Dutch Cardiovascular Alliance; University Medical Center Groningen; Dutch Heart Foundation; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Maastricht University; AstraZeneca BV; UMC Utrecht; Radboud University Medical Center; Siemens Healthineers Nederland BV; University of Twente; Roche Diagnostics Nederland BV; Luscii healthtech BV; Happitech BV; Stichting Radboud Universiteit; Stichting Netherlands Heart Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients
Conditions: Type2 Diabetes Interventions: Drug: AJU-A51; Drug: A51R2; Drug: A51R3; Drug: AJU-A51 Placebo; Drug: A51R2 Placebo Sponsors: AJU Pharm Co., Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Doxycycline in Type II Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin 100mg; Drug: Doxycyclin Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment
Conditions: Type 2 Diabetes Mellitus; Mild Cognitive Impairment Interventions: Other: Olfactory Training Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Pilot, Randomized, Parallel Controlled Clinical Trial
Conditions: Type 2 Diabetes Mellitus; Mild Cognitive Impairment Interventions: Other: Olfactory Training Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Food Insecurity Reduction & Strategy Team
Conditions: Diabetes Mellitus, Type 2; Food Insecurity; Diabetes Mellitus, Type 1 Interventions: Other: Nutrition program Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
Conditions: Type 2 Diabetes Mellitus (T2DM) Interventions: Drug: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets; Drug: Dapagliflozin tablets and Metformin HCl extended-release tablets Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Evaluating the Efficacy and Quality of Life Impact of Transitioning to Advanced Hybrid Closed-Loop Insulin Pump Therapy in Romanian Children With Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1 Interventions: Device: Switching to the Medtronic 780G insulin pump Sponsors: ELIAS Emergency University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Closed Loop and Education for Hypoglycemia Awareness Restoration
Conditions: Diabetes Mellitus, Type 1 Interventions: Device: Omnipod 5 or Medtronic 780G; Behavioral: My HypoCOMPaSS Education; Behavioral: HARPdoc Education Sponsors: Milton S. Hershey Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Minnesota; University of Kentucky; University of Pennsylvania; University of California, San Diego; AdventHealth; University of Leicester; University of Sheffield; University of Melbourne; Jaeb Center for Health Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Effect of Diabetes Self-management Education and Support on Glycemic Control Among Patients With Type 2 Diabetic
Conditions: Diabetes Mellitus, Type 2 Interventions: Behavioral: what ' s app ongoing support; Behavioral: usual care Sponsors: University of Jordan Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Type 2 Diabetes and Binge Eating Disorder (BED)
Conditions: Diabetes Mellitus, Type 2; Binge-Eating Disorder Interventions: Behavioral: BED treatment; Other: Waitlist Sponsors: Odense University Hospital; Jascha Fonden; Independent Research Fund Denmark Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Determinants of Glycaemic Control in Children With Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1 Interventions: Other: Determinants of T1D glycaemic control Sponsors: IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: NNC0519-0130; Drug: Placebo; Drug: Trizepatide Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Cohort Study on Plant-based Diets (COPLANT Study)
Conditions: Dietary Exposure; Diabetes Mellitus, Type 2; Cardiovascular Diseases; Bone Loss; Sustainability; Exposure; Obesity; Vitamin Deficiency; Mineral Deficiency Sponsors: German Federal Institute for Risk Assessment; Max Rubner-Institut; University of Bonn; Research Institute for Plant-Based Nutrition; University of Jena; University of Regensburg; Heidelberg University; University of Vienna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies
ConclusionFIONA is evaluating the use of finerenone in children with CKD and proteinuria. Should safety, tolerability, and efficacy be demonstrated, finerenone could become a useful additional therapeutic agent in managing proteinuria and improving kidney outcomes in children with CKD.Trial registrationClinicalTrials.gov NCT05196035. Registered on 19 January 2022. (Source: Trials)
Source: Trials - March 21, 2024 Category: Research Source Type: clinical trials
